GlaxoSmithKline PLC Correlations
| GSK Stock | 1,342 32.50 2.48% |
The current 90-days correlation between GlaxoSmithKline PLC and Axfood AB is 0.09 (i.e., Significant diversification). The correlation of GlaxoSmithKline PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
GlaxoSmithKline PLC Correlation With Market
Significant diversification
The correlation between GlaxoSmithKline PLC and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC and DJI in the same portfolio, assuming nothing else is changed.
GlaxoSmithKline |
The ability to find closely correlated positions to GlaxoSmithKline PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GlaxoSmithKline PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GlaxoSmithKline PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GlaxoSmithKline PLC to buy it.
Moving together with GlaxoSmithKline Stock
| 0.9 | 0QKN | Chocoladefabriken Lindt | PairCorr |
| 0.64 | RKW | Rockwood Realisation PLC | PairCorr |
| 0.75 | PEYS | Princess Private Equity | PairCorr |
Moving against GlaxoSmithKline Stock
| 0.73 | CAT | CATCo Reinsurance | PairCorr |
| 0.7 | DEC | Diversified Energy | PairCorr |
| 0.63 | 0JYM | Markel Corp | PairCorr |
| 0.56 | CATC | CATCo Reinsurance Opps | PairCorr |
| 0.5 | NBS | Nationwide Building Earnings Call This Week | PairCorr |
| 0.34 | TYT | Toyota Motor Corp | PairCorr |
Related Correlations Analysis
| 0.47 | 0.74 | -0.56 | 0.56 | 0.2 | 0R6R | ||
| 0.47 | 0.88 | -0.94 | 0.92 | -0.36 | IHC | ||
| 0.74 | 0.88 | -0.92 | 0.95 | -0.3 | VINO | ||
| -0.56 | -0.94 | -0.92 | -0.94 | 0.48 | 0GW8 | ||
| 0.56 | 0.92 | 0.95 | -0.94 | -0.43 | SPI | ||
| 0.2 | -0.36 | -0.3 | 0.48 | -0.43 | THRL | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between GlaxoSmithKline Stock performing well and GlaxoSmithKline PLC Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GlaxoSmithKline PLC's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 0R6R | 0.84 | (0.22) | 0.00 | (0.89) | 0.00 | 1.34 | 11.23 | |||
| IHC | 1.53 | (0.80) | 0.00 | (3.40) | 0.00 | 0.00 | 11.63 | |||
| VINO | 0.67 | (0.32) | 0.00 | (2.98) | 0.00 | 0.00 | 7.79 | |||
| 0GW8 | 1.71 | 0.38 | 0.15 | 1.62 | 1.69 | 4.01 | 12.62 | |||
| SPI | 0.88 | (0.27) | 0.00 | (0.74) | 0.00 | 1.39 | 7.59 | |||
| THRL | 0.95 | 0.02 | (0.07) | 0.46 | 1.22 | 2.21 | 6.00 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in GlaxoSmithKline PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
GlaxoSmithKline PLC Corporate Management
Elected by the shareholders, the GlaxoSmithKline PLC's board of directors comprises two types of representatives: GlaxoSmithKline PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GlaxoSmithKline. The board's role is to monitor GlaxoSmithKline PLC's management team and ensure that shareholders' interests are well served. GlaxoSmithKline PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GlaxoSmithKline PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Luke Miels | Chief Officer | Profile | |
| Emma Walmsley | CEO Director | Profile | |
| Sally Jackson | Senior Office | Profile | |
| James Ford | Senior Compliance | Profile |